Skip to main content
. Author manuscript; available in PMC: 2014 Feb 12.
Published in final edited form as: Brain Res. 2012 Mar 27;1456:14–21. doi: 10.1016/j.brainres.2012.03.045

Fig. 4.

Fig. 4

EAAT2 mRNA concentration in (A) NAc (n=16) [F (1,14)=3.340, p<0.089] and (B) mPFC (n=16) [F (1,14)=7.101, p<0.018], in ceftriaxone+methamphetamine-treated (black columns) and saline+methamphetamine (clear columns) control groups at 4 h following the last ceftriaxone administered during simulated addiction (p<0.018).